The team tested six different HIV reverse
transcriptase inhibitors to see if they could block L1 activity and the interferon response.
Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending granting of marketing authorization for two HIV-1 medicines: DELSTRIGO, a once-daily fixed-dose combination tablet of doravirine (100 mg), lamivudine (3TC, 300 mg) and tenofovir disoproxil fumarate; and PIFELTRO (doravirine, 100 mg), a new non-nucleoside reverse
transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral medicines.
It was reported on Friday that the trials, named GEMINI-1 and GEMINI-2, evaluated the 2DR against a three-drug regimen of dolutegravir and two nucleoside reverse
transcriptase inhibitors in HIV-1 patients with baseline viral loads under 500,000 copies per ml.
Summary: Quantitative structure-activity relationships were constructed for 107 inhibitors of HIV-1 reverse
transcriptase that are derivatives of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
The pooled, open-label study reported on 1,028 individuals who met a base criteria of stable viral suppression (viral load fewer than 50 copies/mL) by a first or second CAR regimen consisting of two nucleoside reverse
transcriptase inhibitors (NR-TIs) plus a third drug (nonnucleoside reverse
transcriptase inhibitors, integrase strand transfer inhibitors, or a protease inhibitor) for a minimum of 6 months at time of screening.
This family of viruses uses molecular machinery called reverse
transcriptase to reproduce.
Researchers from the Republic of Korea isolated a population of stem cells derived from dental tissues of third molars and found that human dental papilla stem cells--DpaSCs that develop into dentin and dental pulp--have biological features similar to bone marrow-derived mesenchymal stem cells (MSCs) in terms of telomere length, telomerase activity and reverse
transcriptase (Rtase) activity.
Rifampicin, a key component of TB treatment, is a potent inducer of drug metabolism and decreases plasma concentrations of many co-administered drugs, including non-nucleoside reverse
transcriptase inhibitors, protease inhibitors and integrase inhibitors.
Thermo Fisher Scientific, the world leader in serving science, have announced that the DuPont Qualicon BAX[R] System Reverse
Transcriptase 8-hour Listeria Assay is now available alongside the Oxoid range in Europe, Canada, Australia and New Zealand.
It inhibited HIV-1 reverse
transcriptase with [IC.sub.50] of 0.23 [mu]M.